$BRST
Broad Street Realty, Inc.

2017 Q4 Form 10-K Financial Statement

#000143774918006027 Filed on April 02, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 2016 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $330.0K $698.8K $210.0K
YoY Change 57.14% -18.69% 50.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $808.00
YoY Change
% of Gross Profit
Operating Expenses $330.0K $698.8K $210.0K
YoY Change 57.14% -18.69% 50.0%
Operating Profit -$698.8K
YoY Change -18.69%
Interest Expense $0.00 $17.00K -$10.00K
YoY Change -100.0% 28.73%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$330.0K -$715.8K -$220.0K
YoY Change 50.0% -17.97% 57.14%
Income Tax
% Of Pretax Income
Net Earnings -$330.0K -$715.8K -$220.0K
YoY Change 50.0% -17.97% 57.14%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$131.5K -$472.1K -$211.5K
COMMON SHARES
Basic Shares Outstanding 10.57M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q4 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $710.0K $708.4K
YoY Change
Cash & Equivalents $708.4K $708.4K $450.00
Short-Term Investments
Other Short-Term Assets $40.00K $38.19K $140.0K
YoY Change -71.43% 20.47% 1300.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $746.6K $746.6K $142.2K
YoY Change 425.19% 2255.11% -57.71%
LONG-TERM ASSETS
Property, Plant & Equipment $21.81K $21.81K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $21.81K $21.81K
YoY Change -80.17%
TOTAL ASSETS
Total Short-Term Assets $746.6K $746.6K $142.2K
Total Long-Term Assets $21.81K $21.81K
Total Assets $768.4K $768.4K $142.2K
YoY Change 440.53% 442.26% -57.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.00K $66.32K $62.04K
YoY Change 12.83% -30.87% 46.65%
Accrued Expenses $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $30.00K $33.19K $470.0K
YoY Change -93.62% -92.97%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $126.9K $126.9K $896.8K
YoY Change -85.85% -85.85% 190.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $126.9K $126.9K $896.8K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $126.9K $126.9K $896.8K
YoY Change -85.85% -85.85% 190.54%
SHAREHOLDERS EQUITY
Retained Earnings -$111.2M -$110.5M
YoY Change 0.65% 0.8%
Common Stock $26.11K $10.57K
YoY Change 147.04% -89.76%
Preferred Stock
YoY Change
Treasury Stock (at cost) $70.69K
YoY Change 0.0%
Treasury Stock Shares $566.00
Shareholders Equity $641.5K $641.5K -$754.6K
YoY Change
Total Liabilities & Shareholders Equity $768.4K $768.4K $142.2K
YoY Change 440.53% 440.54% -57.71%

Cashflow Statement

Concept 2017 Q4 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$330.0K -$715.8K -$220.0K
YoY Change 50.0% -17.97% 57.14%
Depreciation, Depletion And Amortization $0.00 $808.00
YoY Change
Cash From Operating Activities -$320.0K -$835.6K -$250.0K
YoY Change 28.0% 21.33% 78.57%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $22.62K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$140.0K -$50.00K
YoY Change
Cash From Investing Activities -$130.0K -$72.62K
YoY Change -33.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 1.616M 180.0K
YoY Change -94.44% 242.54% 1700.0%
NET CHANGE
Cash From Operating Activities -320.0K -835.6K -250.0K
Cash From Investing Activities -130.0K -72.62K
Cash From Financing Activities 10.00K 1.616M 180.0K
Net Change In Cash -440.0K 707.9K -70.00K
YoY Change 528.57% -316.54% -46.15%
FREE CASH FLOW
Cash From Operating Activities -$320.0K -$835.6K -$250.0K
Capital Expenditures $0.00 $22.62K
Free Cash Flow -$320.0K -$858.3K
YoY Change 24.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Document Type
DocumentType
10-K
CY2017Q2 dei Entity Public Float
EntityPublicFloat
19589092
CY2017 mamp Common Stock Shares Subscribed Value
CommonStockSharesSubscribedValue
1940005
CY2017 mamp Conversion Of Preferred Stock Dividends To Common Stock
ConversionOfPreferredStockDividendsToCommonStock
301656
CY2016 mamp Conversion Of Preferred Stock Dividends To Common Stock
ConversionOfPreferredStockDividendsToCommonStock
CY2017 mamp Decrease In Deferred Tax Assets
DecreaseInDeferredTaxAssets
1067000
CY2017 mamp Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0017
CY2016 mamp Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.12
CY2017 mamp Effective Income Tax Rate Reconciliation True Ups
EffectiveIncomeTaxRateReconciliationTrueUps
0.1202
CY2016 mamp Effective Income Tax Rate Reconciliation True Ups
EffectiveIncomeTaxRateReconciliationTrueUps
0
CY2017 mamp Fractional Share Rounding
FractionalShareRounding
CY2016Q4 mamp Net Working Capital
NetWorkingCapital
754634
CY2017Q4 mamp Net Working Capital
NetWorkingCapital
620000
CY2017 mamp Percentage Of Income Tax Examination Likelihood Of Tax Benefits Being Realized Upon Settlement
PercentageOfIncomeTaxExaminationLikelihoodOfTaxBenefitsBeingRealizedUponSettlement
0.5
CY2017Q4 mamp Preferred Stock Amount Of Preferred Dividends Undeclared And Unaccrued
PreferredStockAmountOfPreferredDividendsUndeclaredAndUnaccrued
5000
CY2017 mamp Preferred Stock Dividend In Excess Of Payments
PreferredStockDividendInExcessOfPayments
CY2016 mamp Preferred Stock Dividend In Excess Of Payments
PreferredStockDividendInExcessOfPayments
103750
CY2017 mamp Prepaid Insurance Loan Financing
PrepaidInsuranceLoanFinancing
33191
CY2016 mamp Prepaid Insurance Loan Financing
PrepaidInsuranceLoanFinancing
CY2017 mamp Proceeds From Common Stock Subscribed Net Of Expenses
ProceedsFromCommonStockSubscribedNetOfExpenses
1810264
CY2016 mamp Proceeds From Common Stock Subscribed Net Of Expenses
ProceedsFromCommonStockSubscribedNetOfExpenses
CY2017 mamp Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
CY2016 mamp Sharebased Compensation Arrangement By Sharebased Payment Award Options Expired In Period Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue
0
CY2017 mamp Sharebased Compensation Arrangement By Sharebased Payment Award Options Expired In Period Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue
0
CY2016 mamp Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
0
CY2017 mamp Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
CY2017 mamp Stock Issued For Cash Dividends Payable
StockIssuedForCashDividendsPayable
CY2016 mamp Stock Issued For Cash Dividends Payable
StockIssuedForCashDividendsPayable
29249
CY2017 mamp Valuation Allowance Percentage Of Deferred Tax Assets
ValuationAllowancePercentageOfDeferredTaxAssets
1
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
66319
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
95944
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
808
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
111861799
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
109836007
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
165000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10375
CY2017Q4 us-gaap Assets
Assets
768381
CY2016Q4 us-gaap Assets
Assets
142153
CY2017Q4 us-gaap Assets Current
AssetsCurrent
746573
CY2016Q4 us-gaap Assets Current
AssetsCurrent
142153
CY2017Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
21808
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
CY2017 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">te <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Principles of Consolidation and Basis of Presentation</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The c<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">onsolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany account balances have been eliminated in consolidation. The accompanying Financial Statements give effect to all adjustments necessary to present fairly the financial position and results of operations and cash flows of the Company and its subsidiaries.</div></div></div>
CY2016Q4 us-gaap Cash
Cash
450
CY2017Q4 us-gaap Cash
Cash
708000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
708382
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
219778
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
713056
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
2125133
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
2838189
CY2016Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
110000
CY2017Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
CY2017 us-gaap Depreciation
Depreciation
808
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
450
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
327382
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
707932
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-326932
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2610568
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1056723
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2610568
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1056723
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
26105
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
10567
CY2017 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
148125
CY2016 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
CY2017Q3 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
148125
CY2017 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
148125
CY2016 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2125133
CY2017Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
2125133
CY2016Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
2838189
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1938103
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2618411
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
7989620
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
187030
CY2016 us-gaap Depreciation
Depreciation
CY2017Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
27361
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
329017
CY2016 us-gaap Dividends Preferred Stock
DividendsPreferredStock
103750
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-26703
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22951
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.9962
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.275
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-1.4908
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0361
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.055
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
117756
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
698774
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
859401
CY2017 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.57
CY2016 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.94
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-29625
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
41802
CY2017 us-gaap Interest Expense
InterestExpense
17002
CY2016 us-gaap Interest Expense
InterestExpense
13208
CY2017 us-gaap Interest Paid Net
InterestPaidNet
17002
CY2016 us-gaap Interest Paid Net
InterestPaidNet
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
13208
CY2017Q4 us-gaap Liabilities
Liabilities
126871
CY2016Q4 us-gaap Liabilities
Liabilities
896787
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
768381
CY2017 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
50000
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
110000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
142153
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
126871
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
896787
CY2017Q4 us-gaap Loans Payable Current
LoansPayableCurrent
33191
CY2016Q4 us-gaap Loans Payable Current
LoansPayableCurrent
CY2017 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Nature of Operations</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">MedAmerica Properties Inc. <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">(the &#x201c;Company&#x201d; or &#x201c;MedAmerica&#x201d;), was originally organized under the laws of the Commonwealth of Massachusetts in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1985,</div> under the name VMS Hotel Investment Trust, for the purpose of investing in mortgage loans. The Company was subsequently reorganized as a Delaware corporation in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1987</div> and changed its name to B.H.I.T. Inc. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010,</div> the Company changed its name from B.H.I.T. Inc. to Banyan Rail Services Inc. From <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> the Company experienced severe losses from an operating subsidiary in the rail services sector. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> after exploring various industries and researching numerous companies, the board of directors elected to pursue investing in commercial real estate. The Company is pursuing the acquisition and management of strategically located medical office buildings.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:3.3pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:32.7pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">017,</div> our board of directors and the holders of a majority of our outstanding shares of common stock approved by written consent amendments to the Company&#x2019;s articles of incorporation to (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) change the name of the Company from &#x201c;Banyan Rail Services Inc.&#x201d; to &#x201c;MedAmerica Properties Inc.,&#x201d; and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) effect a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> reverse stock split of the issued and outstanding shares of common stock of the Company. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 15, 2017, </div>the Company filed these amendments with the Secretary of State of the State of Delaware and the name change and reverse stock split became effective with the Financial Industry Regulatory Authority, Inc. (&#x201c;FINRA&#x201d;) on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 20, 2017. </div>As appropriate, all common stock share quantities have been updated to reflect the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> reverse stock split.</div></div></div>
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1616194
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
471826
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72616
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-835646
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-688758
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-715776
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-872609
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-868901
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-976359
CY2017Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
471826
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-698774
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-859401
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22616
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
60000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
60000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2017 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
27361
CY2016 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
329017
CY2017 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.1
CY2017 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5000
CY2016 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
103750
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
500
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10375
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
500
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10375
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
5
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
104
CY2017Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
38191
CY2016Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
31703
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1940005
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
169138
CY2016 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
471826
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22616
CY2017 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Equipment and Furnishings</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Equipment and furnishings are stated at cost. Depreciation will be computed using the straight-line method over the estimated useful lives of the assets, w<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">hich range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div> years. Expenditures for repairs and maintenance are charged to expense as incurred. For assets sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in income for the period statement of operations</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">.</div></div></div></div>
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21808
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
60000
CY2017 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
363208
CY2016 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111246399
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110530623
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
165000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
5000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8
CY2017Q4 us-gaap Share Price
SharePrice
0.75
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5000
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.30
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.30
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P182D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y273D
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
60000
CY2017 us-gaap Stock Issued1
StockIssued1
1940005
CY2016 us-gaap Stock Issued1
StockIssued1
CY2016Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
220000
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
301656
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
29249
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-129741
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
165000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
641510
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-754634
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
27476
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
70689
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017 us-gaap Treasury Stock Retired Par Value Method Amount
TreasuryStockRetiredParValueMethodAmount
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
566
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements, in conformity with accounting principles generally <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">accepted in the United States (&quot;U.S. GAAP&quot;), requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses and disclosures of contingent assets and liabilities at the date and period ending of the financial statements. Actual results could differ from those estimates.</div></div></div></div>
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1516165
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1038895

Files In Submission

Name View Source Status
0001437749-18-006027-index-headers.html Edgar Link pending
0001437749-18-006027-index.html Edgar Link pending
0001437749-18-006027.txt Edgar Link pending
0001437749-18-006027-xbrl.zip Edgar Link pending
ex_108428.htm Edgar Link pending
ex_108429.htm Edgar Link pending
ex_108430.htm Edgar Link pending
ex_108431.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mamp-20171231.xml Edgar Link completed
mamp-20171231.xsd Edgar Link pending
mamp-20171231_cal.xml Edgar Link unprocessable
mamp-20171231_def.xml Edgar Link unprocessable
mamp-20171231_lab.xml Edgar Link unprocessable
mamp-20171231_pre.xml Edgar Link unprocessable
mamp20171231_10k.htm Edgar Link pending
mamp20171231_10kimg009.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending